Serum magnesium profile in heroin addicts: According to psychiatric comorbidity

Magnesium Research

Volumn 19, Issue 3, 2006, Pages 162-166

  Daini, Silvia ^a,b   Tonioni, F ^a   Barra, A ^a   Lai, C ^a   Lacerenza, R ^a   Sgambato, A ^a   Bria, P ^a   Cittadini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE   (Italy)

Author keywords

Addiction; Magnesium; Psychiatric comorbidity

Indexed keywords

MAGNESIUM;

ADULT; ANXIETY DISORDER; ARTICLE; BLOOD; COMORBIDITY; DEPRESSION; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; MENTAL DISEASE; MOOD DISORDER; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS;

ADULT; ANXIETY DISORDERS; COMORBIDITY; DEPRESSION; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEROIN DEPENDENCE; HUMANS; MAGNESIUM; MALE; MENTAL DISORDERS; MOOD DISORDERS; PERSONALITY DISORDERS;

EID: 33751232018     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: 10.1684/mrh.2006.0003     Document Type: Article

References (18)

1. Ramsey TA, Frazer A, Mendels J. Plasma and erythrocyte cations in affective illness. Neuropsychobiology 1979; 5: 1-10.
2. Widmer J, Stella N, Raffin Y, Bovier P, Gaillard JM, Hilleret H, Tissot R. Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes Res 1993; 6: 33-41.
3. Imada Y, Yoshioka S, Ueda T, Katayama S, Kuno Y, Kawahara R. Relationships between serum magnesium levels and clinical background factors in patients with mood disorders. Psychiatry Clin Neurosci 2002; 56: 509-14.
4. Murck H. Magnesium and affective disorders. Nutr Neurosci 2002; 5: 375-89.
5. Kumar AR, Kurup PA. A hypothalamic digoxin mediated model for conscious and subliminal perception. J Neural Transm 2001; 108: 855-68.
6. Nechifor M, Vaideanu C, Palamaru I, Borza C, Mindreci I. The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia. J Am Coll Nutr 2004; 23: 549S-551S.
7. Kurup RK, Kurup PA. A hypothalamic digoxin-mediated model for autism. Int J Neurosci 2003; 113: 1537-59.
8. Sadlik J, Pach J, Winnik L, Piekoszewski W. Concentration of zinc, copper and magnesium in the serum of drug addicts. Przegl Lek 2000; 57: 563-4.
9. Naderi-Heiden A, Frey R, Presslich O, Frottier P, Willinger U, Blasbichler T, Smetana R, Schmid D, Kasper S. Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxification. Psychiatry Res 2005; 15: 53-63.
10. First MB, Spitzer RL, Gibbon M, Williams JBW. User's Guide for the structured clinical interview for DSM-IV Axis I Disorders (SCID-I). Washington, DC: American Psychiatric Press, 1995.
11. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. User's Guide for the structured clinical interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press, 1995.
12. Le Bon O, Basiaux P, Streel E, Tecco J, Hanak C, Hansenne M, Ansseau M, Pelc I, Verbanck P, Dupont S. Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population group. Drug Alcohol Depend 2004; 7: 175-82.
13. Andreasen NC. Vulnerability to mental illnesses: gender makes a difference, and so does providing good care. Am J Psychiatr 2005; 162: 211-3.
14. Szpanowska-Wohn A, Kolarzyk E, Pach D, Targosz D. Intake of nutrients in daily nutritional ratios by opiate dependent persons during methadone maintenance therapy. Przegl Lek 2004; 61: 332-8.
15. Christensen JD, Kaufman MJ, Levin JM, Mendelson JH, Holman BL, Cohen BM, Renshaw PF. Abnormal cerebral metabolism in polydrug abusers durino early withdrawal. A 31P MR spectroscopy study. Magn Reson Med 1996; 35: 658-63.
16. Muneyyirci-Delale O, Dalloul M, Nacharaju VL, Altura BM, Altura BT. Sex steroid hormones mediate serum ionized magnesium and calcium levels throughout the menstrual cycle in women. Fertil Steril 1998; 69: 958-62.
17. Ciraulo DA, Piechniczek-Buczek J, Iscan EN. Outcome predictors in substance use disorders. Psychiatr Clin North Am 2003; 26: 381-409.
18. Bonci A, Carlezon Jr. WA. Ion channels and intracellular signalling proteins as potential targets for novel therapeutics for addictive and depressive disorders. Pharmacol Therap 2005; 108: 65-75.